Blood Cancer Journal

eISSN: 2044-5385pISSN: 2044-5385
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
11.8
Eigenfactor
0.01 - 0.05
Impact Factor
10 - 15
Scite Index
0.86 5-Year SI
SJR
Q1Oncology
SNIP
2.52
3
Time to Publish
time-to-publish View Chart
3  Mo

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
  • Publisher
    SPRINGERNATURE
  • Language
    English
  • Frequency
    Continuous publication
  • Article Processing Charges
    EUR 3790 | USD 4790 | GBP 3290
  • Publication Time
    14
  • Editorial Review Process
    Anonymous peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 39%
4-6 52%
7-9 9%
>9 1%

Topics Covered

Amyloidosis
Proteasome
Overall survival
Plasma cell leukemia
Minimal residual disease
B-cell lymphoma
Functional validation
Diffuse large B-cell lymphoma
Monoclonal antibody
Lenalidomide
Immunotherapy
Daratumumab
Refractory Multiple Myeloma
Observational study
Monoclonal gammopathy of undetermined significance
Poor prognosis
Creatinine
Thrombosis
Genetic complexity
T-cell leukemia

Recently Published Papers

Year-wise Publication

FAQs

Since when has Blood Cancer Journal been publishing? Faqs

The Blood Cancer Journal has been publishing since 2011 till date.

How frequently is the Blood Cancer Journal published? Faqs

Blood Cancer Journal is published Continuous publication.

Who is the publisher of Blood Cancer Journal? Faqs

The publisher of Blood Cancer Journal is SPRINGERNATURE.

How can I view the journal metrics of Blood Cancer Journal on editage? Faqs

For the Blood Cancer Journal metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Blood Cancer Journal? Faqs

The eISSN number is 2044-5385 and pISSN number is 2044-5385 for Blood Cancer Journal.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Amyloidosis, Proteasome, Overall survival, Plasma cell leukemia, Minimal residual disease, B-cell lymphoma, Functional validation, Diffuse large B-cell lymphoma, Monoclonal antibody, Lenalidomide, Immunotherapy, Daratumumab, Refractory Multiple Myeloma, Observational study, Monoclonal gammopathy of undetermined significance, Poor prognosis, Creatinine, Thrombosis, Genetic complexity, T-cell leukemia.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.